Delivery Order SPE2DB22D1202-SPE2DB25FVBM1

Award Date 6/4/25
Potential Completion Date 6/5/25
Potential Value $36K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $6,643.02 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 11, 2025. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $5,377.08 firm fixed-price delivery order was awarded on June 16, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a completion date of June 17, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $12,257.24 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract has an ultimate completion date of June 9, 2025 and is not set aside for any specific business type. Amerisourcebergen...
This federal contract award is for the delivery of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $31,397.94 firm fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 10, 2025 with a completion date of June 11, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award is for the delivery of ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $2,478.84 firm fixed price delivery order was awarded on June 6, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of June 9, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,525.20 firm fixed-price delivery order is for the supply of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of May 14, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,713.52 Firm Fixed Price Delivery Order contract is for the supply of "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML" pharmaceutical products. The contract has an ultimate completion date of April 22, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a substantial Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical products. The $2,425.46 firm fixed-price Delivery Order contract was awarded on June 4, 2025 by the Defense Logistics Agency (DLA), a defense agency, with a performance period through June 5, 2025. The contract is not set aside. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, holds a substantial $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,055.06 firm fixed-price delivery order contract is for the supply of 4568013712 - ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a medical product. The contract has an ultimate completion date of April 24, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract, valued at $1,580.64, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, on a firm fixed-price basis. This delivery order contract has a completion date of June 6, 2024 and does not utilize any set-aside designations....
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FVBM1
    Delivery Order

This federal contract award is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $36,183.77 firm-fixed-price delivery order contract was awarded on June 4, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of June 5, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 9/3/25, 9:57 AM